Cargando…

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study

We studied the value of circulating tumor DNA (ctDNA) in predicting early postoperative tumor recurrence and monitoring tumor burden in patients with hepatocellular carcinoma (HCC). Plasma‐free DNA, germline DNA, and tissue DNA were isolated from 41 patients with HCC. Serial ctDNAs were analyzed by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Gui‐Qi, Liu, Wei‐Ren, Tang, Zheng, Qu, Wei‐Feng, Fang, Yuan, Jiang, Xi‐Fei, Song, Shu‐Shu, Wang, Han, Tao, Chen‐Yang, Zhou, Pei‐Yun, Huang, Run, Gao, Jun, Sun, Hai‐Xiang, Ding, Zhen‐Bin, Peng, Yuan‐Fei, Dai, Zhi, Zhou, Jian, Fan, Jia, Shi, Ying‐Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763657/ https://www.ncbi.nlm.nih.gov/pubmed/34543520 http://dx.doi.org/10.1002/1878-0261.13105

Ejemplares similares

Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection
por: Liu, Wei-Ren, et al.
Publicado: (2020)

Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis
por: Liu, Wei-Ren, et al.
Publicado: (2020)

CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor
por: Zhu, Gui-Qi, et al.
Publicado: (2023)

ZIP4, a Novel Determinant of Tumor Invasion in Hepatocellular Carcinoma, Contributes to Tumor Recurrence after Liver Transplantation
por: Xu, Xiao, et al.
Publicado: (2014)

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2019)

Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
por: Qu, Wei-Feng, et al.
Publicado: (2023)

Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis
por: Tao, Chen-Yang, et al.
Publicado: (2018)

Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection
por: Qu, Wei-Feng, et al.
Publicado: (2020)

A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2018)

3D Culture of Circulating Tumor Cells for Evaluating Early Recurrence and Metastasis in Patients with Hepatocellular Carcinoma
por: Hu, Cong-Li, et al.
Publicado: (2021)

Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma
por: Zhou, Kai-Qian, et al.
Publicado: (2020)

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2019)

Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis
por: Zhou, Pei-Yun, et al.
Publicado: (2017)

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
por: Yuan, Shu‐Qiang, et al.
Publicado: (2023)

Meta-analysis shows that circulating tumor cells including circulating microRNAs are useful to predict the survival of patients with gastric cancer
por: Zhang, Zhen-yu, et al.
Publicado: (2014)

Magnetic Resonance Diffusion Kurtosis Imaging versus Diffusion-Weighted Imaging in Evaluating the Pathological Grade of Hepatocellular Carcinoma
por: Wang, Guang-Zhi, et al.
Publicado: (2020)

Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study
por: Qu, Wei-Feng, et al.
Publicado: (2022)

Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis
por: Zhou, Yu-Fu, et al.
Publicado: (2021)

Excessive intraoperative blood loss independently predicts recurrence of hepatocellular carcinoma after liver transplantation
por: Liu, Bing, et al.
Publicado: (2015)

Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma
por: Wang, Jian, et al.
Publicado: (2020)

Circulating Galectin-3 and Aldosterone for Predicting Atrial Fibrillation Recurrence after Radiofrequency Catheter Ablation
por: Ruan, Zhong-bao, et al.
Publicado: (2022)

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
por: Yin, Chang-Qing, et al.
Publicado: (2016)

CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis
por: Jin, Lei, et al.
Publicado: (2016)

Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study
por: Zhou, Pei-Yun, et al.
Publicado: (2019)

High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014)

Clinicopathological characteristics and prognostic factors for the recurrence of abdominal desmoid tumors: a retrospective study of 113 patients from two Chinese hospitals
por: Zhou, Si-Cheng, et al.
Publicado: (2021)

Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation
por: Hu, Jie, et al.
Publicado: (2011)

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
por: Zhou, Xinping, et al.
Publicado: (2023)

Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma
por: Tang, Zheng, et al.
Publicado: (2019)

Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors
por: Wei, Hao‐Wen, et al.
Publicado: (2023)

Targeting the Raft-Associated Akt Signaling in Hepatocellular Carcinoma
por: Liu, Yuan, et al.
Publicado: (2014)

Emerging role of long noncoding RNAs in recurrent hepatocellular carcinoma
por: Fang, Yuan, et al.
Publicado: (2021)

CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation
por: Shan, Quan-yuan, et al.
Publicado: (2019)

Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
por: Jia, Ning, et al.
Publicado: (2019)

Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma
por: Wu, Xiaochang, et al.
Publicado: (2022)

Recent advances in recurrent hepatocellular carcinoma therapy
por: Gao, Yu-Xue, et al.
Publicado: (2023)

MicroRNA-29a-5p Is a Novel Predictor for Early Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection
por: Zhu, Hai-Tao, et al.
Publicado: (2012)

White Matter Lesions Predict Recurrent Vascular Events in Patients with Transient Ischemic Attacks
por: Ren, Xiao-Mei, et al.
Publicado: (2018)

The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype
por: Yu, Jing-Jing, et al.
Publicado: (2021)

Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma
por: Chen, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ujqsdk9d8p1o7hruc68hv64lj